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Background: Pulmonary hypertension (pHTN) is prevalent in patients with aortic stenosis (AS). Prior studies have demonstrated inconsistent 
results regarding the association of pHTN with adverse outcomes after aortic valve replacement (AVR). We hypothesized pHTN is associated with an 
increased risk of adverse in-hospital outcomes following AVR.
Methods: Using the Northern New England Cardiovascular Disease Study Group database, we identified 1,116 consecutive patients who underwent 
AVR +/- coronary artery bypass graft surgery for severe AS from 2005-2010 and had pre-operative assessment of pulmonary pressure. Pulmonary 
HTN, defined as a mean PA pressure ≥25 mmHg, was present in 536 patients (48%). We further categorized the severity of pHTN as - mild: PASP 
35-44 mmHg (n=218; 9.4%), moderate: PASP 45-59 mmHg (n=209; 9.0%), severe: PASP ≥ 60 mmHg (n=109; 4.7%). Data were collected on patient 
and procedural characteristics and peri-operative outcomes. Multivariate logistic regression was used to control for case-mix in assessing the 
association of pHTN with adverse events, reported as an odds ratio (OR) with 95% confidence intervals (95% CI).
Results: The rates of adverse events were: 3.8% in-hospital death, 1.8% stroke, 0.5% mediastinitis and 4.9% acute kidney injury (AKI). In-hospital 
mortality increased as the severity of pHTN increased (normal 1.7%, mild 3.7%, moderate 4.3%, severe 13.8%, ptrend<0.001). A similar trend was 
seen for AKI (normal 3.6%, mild 4.4%, moderate 5.5%, severe 13.1%, ptrend=0.001) but not for stroke or mediastinitis. In multivariate logistic 
regression, controlling for known predictors, severe pHTN was significantly associated with in-hospital mortality (OR 6.9, 95% CI 2.5-19.1, p<0.001) 
and post-operative AKI (OR 4.1, 95% CI 1.7-10.0, p=0.002) but not mediastinitis or stroke. Moderate pHTN was not associated with adverse 
outcomes.
Conclusions: In patients with severe AS undergoing AVR the presence of severe pHTN is independently associated with increased in-hospital 
mortality and post-operative AKI.
